Background: Osteoporotic fractures are pre-eminent matter of concern and high economic burden in Pakistan. The prevalence of osteoporosis is anticipated to rise to 11.3 million by 2020, which is alarming. Dual energy x-ray absorptiometry (DEXA) scan is a diagnostic tool for osteoporosis but it reveals static changes in bone metabolism which appears late. There is a need to identify dynamic markers in bone metabolism which can unmask early changes. Procollagen Type I- N terminal Propeptide (P1NP) is a recommended bone formation biomarker by International osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry (IFCC) which is less affected by food intake and circadian rhythm variability, but its diagnostic accuracy needs to be assessed. Aim: To evaluate the diagnostic accuracy of P1NP in osteoporosis and osteopenia. Methods: This cross-sectional study with 267 postmenopausal women was conducted at Ziauddin University, Karachi, Pakistan. Demographic variables were taken by self-designed, structured questionnaire. P1NP levels were detected by using electrochemilluminescent technique while DEXA Scan was used to estimate bone mineral density (BMD). Cases were distributed into three groups on the basis of t-score from DEXA scan on hip and spine separately. Mean, median, SD and quartiles were used to describe P1NP levels in three groups and Box-plot was used to show the distribution of P1NP for three groups. Receiver Operative Characteristic Curve (ROC) was used to identify the cutoff of P1NP level for diagnosis of Osteoporosis and Osteopenia in comparison to normal by taking t-score spine as gold standard. Sensitivity, specificity, Positive predictive value (PPV), Negative predictive value (NPV) and accuracy were measured and were presented in percentages with 95% confidence interval. Pvalue = 0.05 was considered significant. Results: P1NP values for the diagnosis of osteoporosis were ascertained as 83.3% Sensitivity,70.8% specificity with diagnostic accuracy of 75.5% .When used for diagnosis of osteopenia the sensitivity, specificity and accuracy recorded were 56.0%, 70.8% and 65.11% respectively. Conclusion: P1NP can be used as reliable marker to predict spinal osteoporosis.